Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer

Practical Radiation Oncology(2020)10.1016/j.prro.2020.02.013Source: DataRank Database

A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer is a research paper published in Practical Radiation Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.11)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Patrick A. Kupelian ORCID,Daniel G. Petereit ORCID,C.A. Lawton,Nick Anger,Heather M. Geye

Live enrichment

PubMed:32169590 PMC:PMC7483248 OpenAlex:https://openalex.org/W3010661922

NCI NIH HHS

Grant: R01 CA106835

National Institutes of Health

Grant: 1R01CA106835-01A2

Hypofractionated IMRT for Localized Prostate Cancer

National Cancer Institute

FWCI

0.11

Citation Percentile

0.4%

Citation Trend

2023

2024

2025

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7483248

publisherhttps://api.elsevier.com/content/article/PII:S187985002030059X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S187985002030059X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.prro.2020.02.013

Fields of Study

Prostate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesProstate Cancer Treatment and Research03 medical and health sciences0302 clinical medicine

MeSH Terms

Radiation Dose HypofractionationAgedAged, 80 and overAndrogen AntagonistsHumansMaleMiddle AgedProspective StudiesProstatic NeoplasmsUrogenital SystemProstate-Specific Antigen

Keywords

MedicineProstate cancerToxicityUrologyRadiation therapyProstateClinical trialProspective cohort studyInternal medicineCancerNuclear medicineOncologyAged, 80 and overMaleProstatic NeoplasmsUrogenital SystemAndrogen AntagonistsMiddle AgedProstate-Specific AntigenHumansRadiation Dose HypofractionationProspective StudiesAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer

FAIR Checklist

Authors (8)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)